211![IMPORTANT REVISIONS TO PRESCRIBING INFORMATION FOR SEREVENT® (salmeterol xinafoate) AND ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder) GlaxoSmithKline PO Box 13398 IMPORTANT REVISIONS TO PRESCRIBING INFORMATION FOR SEREVENT® (salmeterol xinafoate) AND ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder) GlaxoSmithKline PO Box 13398](https://www.pdfsearch.io/img/69bbab10987600512c1888b27ff62e6e.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
212![Consumer Health Information www.fda.gov/consumer www.fda.gov/consumer/updates/asthmameds051308.html FDA Safety Update: Consumer Health Information www.fda.gov/consumer www.fda.gov/consumer/updates/asthmameds051308.html FDA Safety Update:](https://www.pdfsearch.io/img/855b1cf8e502e1c223faea1472ce409e.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
213![Adult Asthma Information Pack Adult Asthma Information Pack](https://www.pdfsearch.io/img/6fe815afd166bd639328bea185a94395.jpg) | Add to Reading ListSource URL: www.mhcs.health.nsw.gov.auLanguage: English |
---|
214![Consistency of Pregnancy Labeling Across Different Therapeutic Classes Consistency of Pregnancy Labeling Across Different Therapeutic Classes](https://www.pdfsearch.io/img/e3d7ec65cf5fa59b8403f77643939760.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
215![FOOD AND DRUG ADMINISTRATION (FDA) FOOD AND DRUG ADMINISTRATION (FDA)](https://www.pdfsearch.io/img/7d14bd050783f7fc5ab294414d47e735.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
216![U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may](https://www.pdfsearch.io/img/c2b6350865ee8c67f7b8c81624dd18fc.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
217![The following is a list of the most commonly prescribed drugs. It represents an abbreviated version of the drug list (formulary) that is at the core of your prescription-drug benefit plan. The list is not all-inclusive a The following is a list of the most commonly prescribed drugs. It represents an abbreviated version of the drug list (formulary) that is at the core of your prescription-drug benefit plan. The list is not all-inclusive a](https://www.pdfsearch.io/img/b31edf352473894cbb0d4cad135da3e1.jpg) | Add to Reading ListSource URL: www.emblemhealth.comLanguage: English - Date: 2014-07-15 16:19:36
|
---|
218![[removed]Federal Register / Vol. 68, No[removed]Tuesday, July 8, [removed]Notices TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued Item [removed]Federal Register / Vol. 68, No[removed]Tuesday, July 8, [removed]Notices TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued Item](https://www.pdfsearch.io/img/7627e2a32b1b66fc30ae1457571d22a9.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
219![Age and Risks of FDA−Approved Long-Acting β2-Adrenergic Receptor Agonists Ann W. McMahon, Mark S. Levenson, Bradley W. McEvoy, Andrew D. Mosholder and Dianne Murphy Pediatrics; originally published online October 24, Age and Risks of FDA−Approved Long-Acting β2-Adrenergic Receptor Agonists Ann W. McMahon, Mark S. Levenson, Bradley W. McEvoy, Andrew D. Mosholder and Dianne Murphy Pediatrics; originally published online October 24,](https://www.pdfsearch.io/img/9e8a45dfd7a2434a3dc1bae84e1705f4.jpg) | Add to Reading ListSource URL: pediatrics.aappublications.orgLanguage: English |
---|
220![FLUTICASONE PROPIONATE OINTMENT, 0.005% For Dermatologic Use Only Not for Ophthalmic Use DESCRIPTION: FLUTICASONE PROPIONATE OINTMENT, 0.005% For Dermatologic Use Only Not for Ophthalmic Use DESCRIPTION:](https://www.pdfsearch.io/img/374bbe0e9e264f7781f1fb654565b7db.jpg) | Add to Reading ListSource URL: www.fougera.comLanguage: English - Date: 2009-11-24 10:11:58
|
---|